Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness

Vaccine

Volumn 33, Issue 11, 2015, Pages 1313-1316

  Jackson, Michael L ^a   Rothman, Kenneth J ^b  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Bias (Epidemiology); Human; Influenza; Methodology; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; HUMAN; INFLUENZA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RAPID TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIMULATION; CASE CONTROL STUDY; COMPUTER SIMULATION; IMMUNOLOGY; INCIDENCE; INFLUENZA, HUMAN;

CASE-CONTROL STUDIES; COMPUTER SIMULATION; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; OBSERVATIONAL STUDIES AS TOPIC; SENSITIVITY AND SPECIFICITY; VACCINE POTENCY;

EID: 84924058651     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.01.069     Document Type: Article

References (22)

1. Kissling E., Valenciano M., Larrauri A., Oroszi B., Cohen J.M., Nunes B., et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013, 18.
2. McNeil S., Shinde V., Andrew M., Hatchette T., Leblanc J., Ambrose A., et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro Surveill 2014, 19.
3. Ohmit S.E., Thompson M.G., Petrie J.G., Thaker S.N., Jackson M.L., Belongia E.A., et al. Influenza vaccine effectiveness in the 2011-2012 season: Protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2013.
4. Foppa I.M., Haber M., Ferdinands J.M., Shay D.K. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31:3104-3109.
5. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31:2165-2168.
6. Orenstein E.W., De Serres G., Haber M.J., Shay D.K., Bridges C.B., Gargiullo P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
7. Rothman K.J., Greenland S., Lash T.L. Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia PA, [Chapter 7]. 3rd ed.
8. Atmar R.L., Baxter B.D., Dominguez E.A., Taber L.H. Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol 1996, 34:2604-2606.
9. Irving S.A., Vandermause M.F., Shay D.K., Belongia E.A. Comparison of nasal and nasopharyngeal swabs for influenza detection in adults. Clin Med Res 2012, 10:215-218.
10. Lopez Roa P., Catalan P., Giannella M., Garcia de Viedma D., Sandonis V., Bouza E. Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients. Diagn Micr Infec Dis 2011, 69:428-431.
11. Kissling E., Valenciano M., Buchholz U., Larrauri A., Cohen J.M., Nunes B., et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill 2014, 19.
12. Suzuki M., Camacho A., Ariyoshi K. Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs. Epidemiol Infect 2014, 142:2642-2646.
13. Broome C.V., Facklam R.R., Fraser D.W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980, 303:549-552.
14. Skowronski D.M., Gilbert M., Tweed S.A., Petric M., Li Y., Mak A., et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep 2005, 31:181-191.
15. Koepsell T.D., Weiss N.S. Epidemiologic methods: studying the occurrence of illness 2003, Oxford University Press, New York City, NY, [Chapter 10].
16. Castilla J., Beristain X., Martinez-Artola V., Navascues A., Garcia Cenoz M., Alvarez N., et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre. Spain Vaccine 2012, 30:539-543.
17. Patel M., Pedreira C., De Oliveira L.H., Umana J., Tate J., Lopman B., et al. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics 2012, 130:e365-e372.
18. Gautam R., Lyde F., Esona M.D., Quaye O., Bowen M.D. Comparison of Premier Rotaclone(R), ProSpecT, and RIDASCREEN(R) rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens. J Clin Virol 2013, 58:292-294.
19. Paul S.K., Tabassum S., Islam M.N., Ahmed M.U., Haq J.U., Shamsuzzaman A.K. Diagnosis of human rotavirus in stool specimens: comparison of different methods. Mymensingh Med J 2006, 15:183-187.
20. Petrie J.G., Ohmit S.E., Johnson E., Cross R.T., Monto A.S. Efficacy studies of influenza vaccines: Effect of end points used and characteristics of vaccine failures. J Infect Dis 2011.
21. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344.
22. Jackson M.L., Nelson J.C., Weiss N.S., Neuzil K.M., Barlow W., Jackson L.A. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008, 372:398-405.